Details

Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections : an international, multicentre, open-label, prospective study
ID Rennerova, Zuzana (Author), ID Picó Sirvent, Leonardo (Author), ID Carvajal Roca, Eva (Author), ID Paśnik, Jaroslaw (Author), ID Logar, Mateja (Author), ID Milosevic, Katarina (Author), ID Majtan, Juraj (Author), ID Ješenák, Miloš (Author)

.pdfPDF - Presentation file, Download (537,45 KB)
MD5: 6C73033677E34C0AF38243C599D43543
URLURL - Source URL, Visit https://www.frontiersin.org/articles/10.3389/fped.2022.999701/full This link opens in a new window

Abstract
Preschool children are particularly susceptible to recurrent upper and lower respiratory tract infections due to their immune immaturity and other contributing factors. Preventing and/or treating children suffering from recurrent respiratory tract infections (RRTIs) is challenging, and it is important to provide more clinical evidence about the safety and efficacy of natural immunomodulating preparations, including β-glucans. The aim of the present study was to assess the incidence of respiratory tract infections (RTIs) in children with a history of RRTIs for a period of 6 months (3 months of pleuran supplementation and 3 months of follow-up) compared with the same period from October to March of the previous year prior to enrolment in the study. A total of 1,030 children with a mean age of 3.49 ± 1.91 years from seven countries were included in this study. The total number of RTIs observed during the study period was significantly lower compared to the same period of the previous year (7.07 ± 2.89 vs. 3.87 ± 3.19; p < 0.001). Analysis of each type of RTI revealed significant reductions in the mean number and duration of infections for all RTI subtypes compared to the previous year. This study also confirmed the beneficial safety profile of pleuran supplementation. In conclusion, pleuran supplementation represents an interesting and prospective supplement in preventing respiratory infections and reveals new strategies for supporting immune functions in the paediatric population.

Language:English
Keywords:pleuran, respiratory tract infections, beta-glucan, children, tolerability
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:8 str.
Numbering:Vol. 10, art. 999701
PID:20.500.12556/RUL-186550 This link opens in a new window
UDC:616.2
ISSN on article:2296-2360
DOI:10.3389/fped.2022.999701 This link opens in a new window
COBISS.SI-ID:147683331 This link opens in a new window
Publication date in RUL:10.09.2026
Views:150
Downloads:50
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Frontiers in pediatrics
Shortened title:Front. pediatr.
Publisher:Frontiers Media
ISSN:2296-2360
COBISS.SI-ID:523096601 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Undetermined
Keywords:plevran, okužba dihalnih poti, beta-glukan, otroci, prenašanje

Projects

Funder:Other - Other funder or multiple funders
Funding programme:Pleuran Ltd

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back